Latest market price
10.89
+0.00%
OverviewShort InterestFilings
DMAAQT40Drugs Made In America Acquisition Corp. Ordinary Shares·NASDAQ
10.89+0.00%
TA
Loading chart...
Screen all →
PCAP+0.00%$10.42OBA+0.05%$10.38CUB+0.00%$10.94EVOX+0.00%$10.14NPAC-0.09%$10.55RTAC+0.10%$10.48MBAV-0.19%$10.71PACH+0.10%$10.38
Snapshot
Index—P/E54.45EPS (ttm)0.20Insider Own—Shs Outstand24.28MPerf Week0.09%
Market Cap264.38MForward P/E—EPS next Y—Insider Trans—Shs Float18.56MPerf Month0.00%
Enterprise Value265.38MPEG—EPS next Q—Short Float0.48%Perf Quarter1.68%
Income6.00MP/S—EPS this Y—Short Ratio4.08Perf Half Y3.03%
Sales0.00P/B1.92EPS next Y—ROA4.15%Short Interest89.09KPerf YTD5.01%
Book/sh5.68P/C—EPS next 5Y—ROE2.92%52W High10.89 0.00%Perf Year5.63%
Cash/sh0.00P/FCF—EPS past 3/5Y—ROIC-1.82%52W Low10.30 5.73%Perf 3Y—
Dividend Est.—EV/EBITDA—Sales past 3/5Y—Gross Margin0.00%Volatility0.07% 0.10%Perf 5Y—
Dividend TTM—EV/Sales—EPS Y/Y TTM-99.60%Oper. Margin0.00%ATR (14)0.01Perf 10Y—
Dividend Ex-Date—Quick Ratio0.02Sales Y/Y TTM—Profit Margin0.00%RSI (14)68.54Recom—
Dividend Gr. 3/5Y—Current Ratio0.02EPS Q/Q—SMA200.18%Beta-0.00Target Price—
Payout0.00%Debt/Eq0.01Sales Q/Q—SMA500.51%Rel Volume0.01Prev Close10.89
Employees2LT Debt/Eq0.00Earnings—SMA2002.42%Avg Volume20.98KPrice10.89
IPO DateJan 27, 2025Option/ShortYes / YesEPS/Sales Surpr.—Net Debt/EBITDA—Volume155Change0.00%
Latest News· Times ET
Sep-19-26
Sep-19-2607:00AM
Costco, BlackBerry To Headline Earnings In A Muted WeekSeekingAlpha
Company

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
Total Revenue
000
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other030
Research and Development
000
Other Operating Expense
200
Operating Income-2-30
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)890
Net Income Before Taxes660
Income Taxes
000
Consolidated Net Income660
Net Income From Continuing Operations660
Net Income660
EPS (Recurring)0.200.19-0.06
EPS (Basic, Before Extraordinaries)0.200.19-0.06
EPS (Diluted)0.200.19-0.06
EBITDA-2-30
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio54.4554.58—
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding20219
Market Capitalization218218—
Operating Lease Expense
———
Insider Trading Volume
$10.99$10.78$10.57$10.36$10.15● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Drugs Made In America Acquisition LLC10% OwnerFeb 18 '25Buy0.0060,00004,188,780Feb 18
Stockwell LynnCEO and Exe. Chair of BoardFeb 18 '25Buy0.0060,00004,188,780Feb 18
Drugs Made In America Acquisition LLC10% OwnerJan 29 '25Buy0.00800,000010,257,143Feb 04
Drugs Made In America Acquisition LLC10% OwnerJan 29 '25Sale1.505,698,3638,547,5454,158,780Feb 04
Stockwell LynnCEO and Executive COBJan 29 '25Sale1.505,698,3638,547,5454,158,780Feb 04
Stockwell LynnCEO and Executive COBJan 29 '25Buy0.00800,0000400,000Feb 04
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.